EMJ Allergy & Immunology 8 [Supplement 1] . 2023

In this issue

This symposium, which took place on 1st December 2022 as part of the European Academy of Allergy and Clinical Immunology (EAACI) FAAM-EUROBAT Digital Conference presented new evidence on the role of human milk oligosaccharides (2 fucosyllactose and lacto-N-neotetraose) in supporting development of the infant microbiota, modulating the immune system, and ultimately improving the clinical management of cow’s milk protein allergy.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given